Spots Global Cancer Trial Database for Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Official Title: A Multi-centre Observational Study on Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients Under Gefitinib Treatment
Study ID: NCT02804100
Interventions
Study Description
Brief Summary: A multi-centre observational, non-interventional study is to dynamically monitor the changes of circulating tumor DNA (ctDNA) in late stage NSCLC patients under Gefitinib treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Wenzhou Medical University, Wenzhou, Zhejiang, China
Contact Details
Name: Wenfeng Li, Ph.D
Affiliation: First Affiliated Hospital of Wenzhou Medical University
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
